Evidence Health
← Back to the full page

Ipratropium Bromide And Albuterol Sulfate

Also sold as Ipratropium Bromide and Albuterol Sulfate, IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE

Medicine summary · from official FDA labels · Oct 19, 2026

6 recalls on record — a recall affects specific batches; check with your pharmacist.

What it’s used for

Ipratropium Bromide and Albuterol Sulfate Inhalation Solution is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator.

How to take it

The recommended dose of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution is one 3 mL vial administered 4 times per day via nebulization with up to 2 additional 3 mL doses allowed per day, if needed. Safety and efficacy of additional doses or increased frequency of administration of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution beyond these guidelines has not been studied and the safety and efficacy of extra doses of albuterol sulfate or ipratropium bromide in addition to the recommended doses of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution have not been studied.

Important warnings

Paradoxical Bronchospasm In the clinical study of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, paradoxical bronchospasm was not observed. However, paradoxical bronchospasm has been observed with both inhaled ipratropium bromide and albuterol products and can be life-threatening.

Common side effects

Adverse reaction information concerning Ipratropium Bromide and Albuterol Sulfate Inhalation Solution was derived from the 12-week controlled clinical trial. ADVERSE EVENTS OCCURRING IN ≥ 1% OF ≥ 1 TREATMENT GROUP(S) AND WHERE THE COMBINATION TREATMENT SHOWED THE HIGHEST PERCENTAGE Body System Albuterol Ipratropium Ipratropium and Albuterol COSTART Term n (%) n (%) n (%) NUMBER OF PATIENTS 761 754 765 N (%) Patients with AE 327 (43.

Interactions

Drug Interactions Anticholinergic agents Although ipratropium bromide is minimally absorbed into the systemic circulation, there is some potential for an additive interaction with concomitantly used anticholinergic medications.

If pregnant or breastfeeding

Pregnancy TERATOGENIC EFFECTS: Pregnancy Category C Albuterol sulfate Pregnancy Category C Albuterol sulfate has been shown to be teratogenic in mice.

Forms & strengths

0.021 MG/ACTUAT Nasal Spray · 0.042 MG/ACTUAT Nasal Spray

Questions to ask your doctor or pharmacist

  • Is this the right medicine for my condition, and how long should I take it?
  • What side effects should I watch for, and which need urgent attention?
  • Does this interact with my other medicines, supplements, or alcohol?
  • What should I do if I miss a dose or take too much?